Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior - sprookjes - yvandenbroek - TriplyDB

Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior

Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior

http://www.wikidata.org/entity/Q35175610

about

Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process.Antipsychotic prescribing for vulnerable populations: a clinical audit at an acute Australian mental health unit at two-time points.A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.Antipsychotic therapeutic drug monitoring: psychiatrists' attitudes and factors predicting likely future use.Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.Safety and tolerability of antipsychotic polypharmacy.Antipsychotic Prescribing Patterns in First-episode Schizophrenia: A Five-year Comparison Antipsychotic polypharmacy: a comprehensive evaluation of relevant correlates of a long-standing clinical practice Predictors of long-term (≥6months) antipsychotic polypharmacy prescribing in secondary mental healthcare.Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales.Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness.Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study.Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials.Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome.Characteristics of Medicaid Recipients Receiving Persistent Antipsychotic Polypharmacy.Combined treatment with a selective PDE10A inhibitor TAK-063 and either haloperidol or olanzapine at subeffective doses produces potent antipsychotic-like effects without affecting plasma prolactin levels and cataleptic responses in rodents.Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison.

P2860

Q26800235-1CEE6BBE-A1C8-4A69-9F90-5799275DFEC5 Q30981989-3A65C71A-5ED2-4A0A-BB3C-AE3674AA7D1D Q33560808-64E54EB7-1A2B-47E1-A0C6-61A3337C4C4D Q35795401-B0F69E02-FF7C-41A1-97B8-A7784679E981 Q35948858-F724BF24-04B8-4FF3-A61B-496471F54B04 Q36057820-21CE0371-98DD-4398-9EA8-35BBE3B4B7E9 Q36062421-08380A7A-8F8C-4F84-AB18-1EEDD3920873 Q36325431-8E215869-0107-4D6F-9787-CBE05507726E Q37029622-4AD69628-6D73-4018-B442-29B4337D04FD Q37042072-47AEAC3E-7160-4266-9A35-5567A4507904 Q37216848-54937D67-5380-4D30-BE37-0B1A34F2D4A2 Q37609168-10644AFA-8CAF-4684-8B55-DD85CD2BE8CC Q38081872-555E54B0-A029-4BEC-B63A-D85C90F63CD7 Q38687957-D6E0225E-5F70-475C-BF2D-11037FD45B2B Q38769838-34C13FE8-6CCD-435C-9DEE-1A3EE5739017 Q47152270-2CD26373-D695-45D4-AC68-97AAC09B6768 Q48321579-B4D6A195-19B5-4F51-95CD-193FB8F022AE Q50124634-F6CB0D52-DF09-40D3-B0BE-B3CAE8DA474F Q50709810-EB1549F1-25A9-46D3-AEA7-5E6D30043492

P2860

Antipsychotic polypharmacy: a survey study of prescriber attitudes, knowledge and behavior

http://www.wikidata.org/entity/Q35175610

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Antipsychotic polypharmacy: a ...... itudes, knowledge and behavior

@ast

Antipsychotic polypharmacy: a ...... itudes, knowledge and behavior

@en

type

label

Antipsychotic polypharmacy: a ...... itudes, knowledge and behavior

@ast

Antipsychotic polypharmacy: a ...... itudes, knowledge and behavior

@en

prefLabel

Antipsychotic polypharmacy: a ...... itudes, knowledge and behavior

@ast

Antipsychotic polypharmacy: a ...... itudes, knowledge and behavior

@en

P1433

Q35175610-5386FAEB-E32D-44D3-A19E-8051B865714C

P1476

Q35175610-7FD3D4CA-F713-43F2-9229-8CEFDA56C43E

P2093

Q35175610-0C9356C5-CE3D-4DFA-A5A6-6ACF88B13B76

Q35175610-3B0A53A1-37BF-415D-A533-6999FA61915C

Q35175610-3C3DFC0D-E642-4545-98D2-46E824934FC2

Q35175610-431AA1E6-F3B8-416E-855D-81897368F637

Q35175610-5EBA9976-A815-4CF8-BBC8-7BB4F8E6641F

Q35175610-C2627D12-3048-4658-B94B-D714B904037D

Q35175610-CC16F940-EFD6-4E33-8F10-F24F4BF64A96

P2860

Q35175610-054D55F4-183B-4A8E-BA34-A9995BFC69EF

Q35175610-0C388C30-0A62-4F33-8249-D27281BC1D1C

Q35175610-0CCC34F6-63FE-46C0-A8D6-E905FEC82B53

Q35175610-12DBE9A5-029F-42A4-A354-AA99202CAE41

Q35175610-2313FF52-254E-41F0-A1DF-A70507431D5C

Q35175610-28773D8D-9403-4DE7-BA83-24480634D434

Q35175610-2DE50C1F-E88F-415A-ADD3-3ABA027F8AF4

Q35175610-34A6FC7A-9622-4D4E-A883-0D560C2A631D

Q35175610-3627D03A-FA70-488C-898E-FE37A1B24FD1

Q35175610-4CDBE922-8EE2-4D0A-9339-A81D43607652

P304

Q35175610-AA7C50F8-9DD7-46DC-BDC3-D9FB6BEE64C9

P31

Q35175610-ED5B29E0-171F-44B0-B4A3-A84BEB1658DB

P356

Q35175610-9040CDEC-0765-49B3-B259-7C6CE074A709

P407

Q35175610-3EF5A040-00EB-41EB-AB5B-52C3622C5466

P433

Q35175610-BC0F621F-9BD9-4155-95FD-1DB32A3377BD

P478

Q35175610-68B0750F-B032-4114-9611-9A7C3D78A573

P577

Q35175610-53D38C3D-1332-47CF-8B85-25E5CDE69C17

P5875

Q35175610-F57A7962-A21B-4A7A-8301-670548CA1830

P698

Q35175610-364C3CE9-FA56-4FD5-ACD8-CB8A98D48DA3

P932

Q35175610-172E8C14-4469-4480-AEDF-B6CF9C6CDE69

P356

J.SCHRES.2011.02.016

P1433

Schizophrenia Research

P1476

Antipsychotic polypharmacy: a ...... itudes, knowledge and behavior

@en

P2093

Christoph U Correll

http://www.w3.org/2001/XMLSchema#string

Jeffrey Nachbar

http://www.w3.org/2001/XMLSchema#string

John M Kane

http://www.w3.org/2001/XMLSchema#string

Juan A Gallego

http://www.w3.org/2001/XMLSchema#string

Ladan Shaikh

http://www.w3.org/2001/XMLSchema#string

Taishiro Kishimoto

http://www.w3.org/2001/XMLSchema#string

Vladimir Olshanskiy

http://www.w3.org/2001/XMLSchema#string

P2860

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder.

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

Use of antipsychosis and adjunctive medications by an inner urban community psychiatric service.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation.

Polypharmacy and excessive dosing: psychiatrists' perceptions of antipsychotic drug prescription.

Schizophrenia, neuroleptic medication and mortality.

Past and present progress in the pharmacologic treatment of schizophrenia.

Antipsychotic medication coprescribing in a large state hospital system.

P304

58-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SCHRES.2011.02.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

131

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50593248

http://www.w3.org/2001/XMLSchema#string

P698

21419603

http://www.w3.org/2001/XMLSchema#string

P932

3159758

http://www.w3.org/2001/XMLSchema#string